Alfa protect: a phase 3, open-label study to evaluate the safety of damoctocog alfa pegol in previously treated children aged 7<12 years with severe hemophilia aJonathan Ducore, Monika Mass Enriquez,Claudia Tueckmantel,Mindy Simpson,Sanjay AhujaAMERICAN JOURNAL OF HEMATOLOGY（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
